Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Femtobiomed Inc. is currently managing 1 pending office action within the Chemistry & Materials technology area. This matter is assigned to a distinct examiner and a distinct art unit. The data reflects a focused prosecution effort with minimal simultaneous actions pending. This approach allows the company to dedicate its attention to the specific technical challenges presented by this application.
HOBBS, MICHAEL L is the busiest examiner for the portfolio, with 1 pending office action. This action constitutes the full extent of the company's active prosecution workload. Practitioners can focus their attention on the specific requirements and history of this examiner to resolve the pending matter. Because the company is only dealing with a distinct examiner and a distinct art unit, there is no risk of conflicting strategies across different examiners. The outcome of this pending action will be the primary indicator of the company's current success in the Chemistry & Materials technology area.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOBBS, MICHAEL L | 1 | 68.9% | +28.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18107466 | Cell Transformation Cartridge, Cell Transformation Device, Cell Transformation System Including Same and Cell Transformation Method Using Same | HOBBS, MICHAEL L | 6d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18107466 | Cell Transformation Cartridge, Cell Transformation Device, Cell Transformation System Including Same and Cell Transformation Method Using Same | HOBBS, MICHAEL L | 6d |
| Art Unit | Apps |
|---|---|
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18107466 | Cell Transformation Cartridge, Cell Transformation Device, Cell Transformation System Including Same and Cell Transformation Method Using Same | HOBBS, MICHAEL L | 1799 | §102§112Other | Final Rejection | 6d | Pending | Feb 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial